▲ Peaking
Health
Targeting Allele-Specific Faulty MRNA In SCNA2 Mutation Patients
Personalized genetic treatments using antisense oligonucleotides show early promise in treating children with rare SCN2A-related epilepsy.
1 trends tracked about this subject — the full history, oldest to newest below.
Personalized genetic treatments using antisense oligonucleotides show early promise in treating children with rare SCN2A-related epilepsy.